0001437749-19-022908.txt : 20191114 0001437749-19-022908.hdr.sgml : 20191114 20191114153020 ACCESSION NUMBER: 0001437749-19-022908 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: McorpCX, Inc. CENTRAL INDEX KEY: 0001535079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 260030631 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54918 FILM NUMBER: 191219513 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET STREET 2: SUITE 1100 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: (415) 526-2655 MAIL ADDRESS: STREET 1: 201 SPEAR STREET STREET 2: SUITE 1100 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Touchpoint Metrics, Inc. DATE OF NAME CHANGE: 20111116 10-Q 1 mccx20190930_10q.htm FORM 10-Q mccx20190930_10q.htm
 

 



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED

September 30, 2019

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number:   000-54918

 

MCORPCX, INC.

(Exact name of registrant as specified in its charter)

 

California

(State or other jurisdiction of incorporation or organization)

 

26-0030631

(I.R.S. Employer Identification No.)

 

201 Spear Street, Suite 1100

San Francisco, CA   94105

(Address of principal executive offices, including zip code)

 

(415) 526-2655

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.   YES      NO

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   YES      NO

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer

Accelerated Filer

Non-accelerated Filer

Smaller Reporting Company

Emerging growth company

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES      NO

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

None

 

N/A

 

N/A

 

Indicated the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: 20,426,158 as of November 11, 2019.   

 

 

 
 

 

 

MCORPCX, Inc.

Form 10-Q Quarterly Report

 

 

TABLE OF CONTENTS

 

 

 

Page

No.

 

 

 

 

Part I. - Financial Information

 3

 

 

  

Item 1.

Financial Statements.

3

 

 

  

 

Consolidated Balance Sheets as of September 30, 2019 (unaudited) and December 31, 2018.

3

 

 

  

 

Consolidated Statements of Operations for the Three and Nine Months ended September 30, 2019 and 2018 (unaudited).

4

 

 

  

 

Consolidated Statements of Shareholders’ Equity for the Three and Nine Months ended September 30, 2019 and 2018 (unaudited).

5

     

 

Consolidated Statements of Cash Flows for the Three and Nine Months ended September 30, 2019 and 2018 (unaudited).

6

 

 

  

 

Notes to Consolidated Financial Statements (unaudited).

7

 

 

  

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations.

11

 

 

  

Item 3.

Quantitative and Qualitative Disclosure about Market Risk.

17

 

 

  

Item 4.

Controls and Procedures.

17

 

 

  

 

Part II. - Other Information

17

 

 

  

Item 1. 

Legal Proceedings.

17

 

  

  

Item 1A.

Risk Factors.

17

 

  

  

Item 2. 

Unregistered Sales of Equity Securities and Use of Proceeds.

17

 

  

  

Item 3. 

Defaults Upon Senior Securities.

18

  

  

  

Item 4. 

Mine Safety Disclosures.

18

  

  

  

Item 5. 

Other Information.

18

 

 

  

Item 6.

Exhibits.

19

 

 

  

Signatures

20

 

 

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1.     FINANCIAL STATEMENTS.

 

 

 

McorpCX, Inc.

Consolidated Balance Sheets

 

   

September 30,

   

December 31,

 
   

2019

   

2018

 
   

(unaudited)

         

Assets

               

Current assets:

               

Cash and cash equivalents

  $ 769,145     $ 1,350,014  

Accounts receivable

    565,470       343,036  

Total current assets

    1,334,615       1,693,050  

Long term assets:

               

Property and equipment, net

    88,182       90,074  

Capitalized software development costs, net

    12,070       108,968  

Other assets

    69,664       72,876  

Total assets

  $ 1,504,531     $ 1,964,968  
                 

Liabilities and Shareholders' Equity

               

Liabilities:

               

Accounts payable and accrued liabilities

  $ 157,596     $ 220,576  

Deferred revenue

    97,187       122,238  

Lease payable

    14,749       -  

Other current liabilities

    1,682       1,536  

Total current liabilities

    271,214       344,350  

Total liabilities

    271,214       344,350  

Shareholders' equity:

               

Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at September 30, 2019 and December 31, 2018

    -       -  

Additional paid-in capital

    6,501,982       6,454,791  

Accumulated deficit

    (5,268,665 )     (4,834,173 )

Total shareholders' equity

    1,233,317       1,620,618  

Total liabilities and shareholders' equity

  $ 1,504,531     $ 1,964,968  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

3

 

 

 

McorpCX, Inc.

Consolidated Statements of Operations

(unaudited)

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2019

   

2018

   

2019

   

2018

 
                                 

Revenue, net

                               

Consulting services

  $ 401,318     $ 772,081     $ 2,497,083     $ 2,567,153  

Products and other

    51,908       161,755       143,581       385,191  

Total revenue, net

    453,226       933,836       2,640,664       2,952,344  

Cost of goods sold

                               

Labor

    304,634       407,421       900,290       1,120,502  

Products and other

    39,228       215,007       270,138       540,130  

Total cost of goods sold

    343,862       622,428       1,170,428       1,660,632  

Gross profit

    109,364       311,408       1,470,236       1,291,712  

Expenses

                               

Salaries and wages

    282,883       251,111       870,813       684,029  

Contract services

    54,590       47,202       126,928       161,453  

Other general and administrative

    289,462       262,851       896,032       749,612  

Total expenses

    626,935       561,164       1,893,773       1,595,094  
                                 

Net operating loss

    (517,571 )     (249,756 )     (423,537 )     (303,382 )
                                 

Interest expense

    (483 )     (645 )     (2,238 )     (1,048 )
                                 

Other income (expense), net

    (6,399 )     (3,775 )     (8,717 )     (4,532 )
                                 

Net loss

  $ (524,453 )   $ (254,176 )   $ (434,492 )   $ (308,962 )
                                 

Net loss per share-basic and diluted

  $ (0.03 )   $ (0.01 )   $ (0.02 )   $ (0.02 )
                                 

Weighted average common shares outstanding-basic and diluted

    20,426,158       20,426,158       20,426,158       20,426,158  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

4

 

 

 

McorpCX, Inc.

Consolidated Statements of Changes in Shareholders’ Equity

(unaudited)

 

   

Nine Months Ended September 30, 2018

 
                           

Retained

         
                   

Additional

   

Earnings

         
   

Common Stock

   

Paid in

   

(Accumulated

         
   

Shares

   

Amount

   

Capital

   

Deficit)

   

Total

 

Balance at December 31. 2017

    20,426,158     $ -     $ 6,428,997     $ (4,422,957 )   $ 2,006,040  

Stock based compensation - stock options

    -       -       3,087       -       3,087  

Net loss

    -       -       -       (202,716 )     (202,716 )

Balance at March 31, 2018

    20,426,158     $ -     $ 6,432,084     $ (4,625,673 )   $ 1,806,411  

Stock based compensation - stock options

    -       -       2,781       -       2,781  

Net income

    -       -       -       147,930       147,930  

Balance at June 30, 2018

    20,426,158     $ -     $ 6,434,865     $ (4,477,743 )   $ 1,957,122  

Stock based compensation - stock options

    -       -       4,981       -       4,981  

Net loss

    -       -       -       (254,176 )     (254,176 )

Balance at September 30, 2018

    20,426,158     $ -     $ 6,439,846     $ (4,731,919 )   $ 1,707,927  

 

 

   

Nine Months Ended September 30, 2019

 
                           

Retained

         
                   

Additional

   

Earnings

         
   

Common Stock

   

Paid in

   

(Accumulated

         
   

Shares

   

Amount

   

Capital

   

Deficit)

   

Total

 

Balance at December 31. 2018

    20,426,158     $ -     $ 6,454,791     $ (4,834,173 )   $ 1,620,618  

Stock based compensation - stock options

    -       -       15,558       -       15,558  

Net income

    -       -       -       4,777       4,777  

Balance at March 31, 2019

    20,426,158     $ -     $ 6,470,349     $ (4,829,396 )   $ 1,640,953  

Stock based compensation - stock options

    -       -       15,730       -       15,730  

Net income

    -       -       -       85,184       85,184  

Balance at June 30, 2019

    20,426,158     $ -     $ 6,486,079     $ (4,744,212 )   $ 1,741,867  

Stock based compensation - stock options

    -       -       15,903       -       15,903  

Net loss

    -       -       -       (524,453 )     (524,453 )

Balance at September 30, 2019

    20,426,158     $ -     $ 6,501,982     $ (5,268,665 )   $ 1,233,317  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

5

 

 

 

McorpCX, Inc.

Consolidated Statements of Cash Flows

(unaudited)

 

   

Nine Months Ended September 30,

 
   

2019

   

2018

 

CASH FLOWS FROM OPERATING ACTIVITIES:

               

Net loss

  $ (434,492 )   $ (308,962 )

Adjustments to reconcile net loss to net cash used in operations:

               

Depreciation, and amortization

    98,790       153,074  

Operating lease ROU asset amortization

    20,498       -  

Stock compensation expense

    47,191       10,849  

Changes in operating assets and liabilities:

               

Accounts receivable

    (222,434 )     (207,134 )

Other assets

    18,546       (35,359 )

Accounts payable and accrued liabilities

    (62,980 )     263,584  

Lease liability

    (21,083 )     -  

Other current liabilities

    146       2,150  

Deferred revenue

    (25,051 )     (11,714 )
                 

Net cash used in operating activities

    (580,869 )     (133,512 )
                 

INVESTING ACTIVITIES

               

Equipment purchases

    -       (4,474 )
                 

Net cash used in investing activities

    -       (4,474 )
                 

FINANCING ACTIVITIES

               

Repayment of notes payable

    -       (8,169 )
                 

Net cash used in financing activities

    -       (8,169 )
                 

Decrease in cash and cash equivalents

    (580,869 )     (146,155 )
                 

Cash and cash equivalents, beginning of period

    1,350,014       1,616,076  
                 

Cash and cash equivalents, end of period

  $ 769,145     $ 1,469,921  
                 

Supplemental disclosure of cash flow information:

               

Interest paid

  $ 2,238     $ 1,048  

Non-cash transactions:

               

ROU asset and operating lease obligation recognized upon adoption of ASU 2016-02

  $ 34,164     $ -  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

  

6

 

 

MCORPCX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2019

(unaudited)

  

 

 

 

Note 1: Organization and Basis of Presentation

 

McorpCX, Inc. (“we,” “us,” “our,” or the “Company””) was incorporated in the State of California on December 14, 2001. We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective October 18, 2011. During Q1 2015, the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On June 11, 2015, at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc.

 

The Company formed a wholly owned subsidiary, McorpCX, LLC (“McorpCX LLC”) as a limited liability company in the state of Delaware on December 14, 2017. On August 16, 2018, the Company entered into a contribution agreement with its wholly owned subsidiary McorpCX LLC, pursuant to which the Company transferred to McorpCX LLC all of the Company’s assets and liabilities related to the Company’s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company.

 

We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization. 

 

The consolidated financial statements and related disclosures as of and for the three and nine months ended September 30, 2019 and 2018, are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of December 31, 2018 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended December 31, 2018, filed on Form 10-K with the SEC on April 1, 2019.  The results of operations for the three and nine months ended September 30, 2019, are not necessarily indicative of the results to be expected for the full year.

 

 

Note 2: Recent Accounting Pronouncements

 

In February 2016, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”) to increase the transparency and comparability about leases among entities. Additional ASUs have been issued subsequent to ASU 2016-02 to provide supplementary clarification and implementation guidance for leases related to, among other things, the application of certain practical expedients, the rate implicit in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU 2016-02 and these additional ASUs are now codified as Accounting Standards Codification Standard 842 - “Leases” (“ASC 842”). ASC 842 supersedes the lease accounting guidance in Accounting Standards Codification 840 “Leases” (“ASC 840”) and requires lessees to recognize a lease liability and a corresponding lease asset for virtually all lease contracts. It also requires additional disclosures about leasing arrangements. The Company’s consolidated financial statements for the periods prior to the adoption of ASC 842 are not adjusted and are reported in accordance with the Company’s historical accounting policy. As of the date of implementation on January 1, 2019, the impact of the adoption of ASC 842 resulted in the recognition of a right of use asset, included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of approximately $34,000. We elected the package of practical expedients permitted under the transition guidance.

 

As the right of use asset and the lease payable obligation were the same upon adoption of ASC 842, there was no cumulative effect impact on the Company’s retained earnings.

 

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC 220, Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company adopted ASU 2018-02 effective January 1, 2019. The adoption of this standard did not have a material impact on the consolidated financial statements.

 

7

 

 

 

Note 3. Revenues

 

Consulting Service Revenues

 

The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the analysis of a client customer’s experience. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has no alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.

 

Product and other revenue

  

Product and other revenue during 2018 and 2019 has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue. The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services. Customer licenses for Touchpoint Mapping are not subject to the licensing guidance in Topic 606 because the customer can’t take possession of the software at any time and the customer would not be able to operate the software on its own or with another third party. Fees charged to customers of Touchpoint Mapping may include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does not affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do not unbundle such services into separate performance obligations as their pattern of transfer does not differ.

 

Deferred Revenues (Contract Liabilities)

 

The Company records deferred revenues when cash payments are received, including amounts which are refundable.

 

Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.

 

The aggregate amount of the fees received from customers that are allocated to each customer’s respective performance obligation that is unsatisfied (or partially unsatisfied) is $97,187 as of September 30, 2019 and included in deferred revenue on the accompanying consolidated balance sheets. The Company expects to recognize revenue of $97,187 in 2019 related to these unsatisfied (or partially unsatisfied) performance obligations. Deferred revenue is not expected to be recognized beyond fiscal year 2019. 

 

During the nine months ended September 30, 2019 and 2018, we recognized revenue of $122,238 and $80,057, related to our contract liabilities included in deferred revenue at December 31, 2018 and 2017, respectively. There was no revenue recognized for the three months ended September 30, 2019 and 2018 related to deferred revenue balances as of December 31, 2018 and 2017.

 

Practical Expedients and Exemptions

 

Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less and the commissions are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.

 

The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

 

8

 

 

 

Note 4: Capitalized Software Development Costs 

 

Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. There were no capitalizable costs during the three and nine months ended September 30, 2019 and 2018.

 

Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the three-year expected useful life of the software. Capitalized software development costs, net of amortization, were $12,070 and $108,968 as of September 30, 2019 and December 31, 2018, respectively. Amortization expense incurred during the three months ended September 30, 2019 and 2018 was $19,753 and $48,458, respectively, and during the nine months ended September 30, 2019 and 2018 was $96,898 and $145,375, respectively, and is included in cost of goods sold in the consolidated statements of operations.

  

 

Note 5: Stock-Based Compensation

 

Our stock-based compensation plan was originally established in 2008. The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could not exceed 30% of any outstanding issue or 2,500,000 shares, whichever was the lower amount.

 

In December 2015, we adopted a revised share option plan in which Plan Shares cannot exceed 10% of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a 10-year term. This share option plan was approved by the Company’s shareholders at the annual meeting of shareholders on August 10, 2016.

 

To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin No. 110. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

 

The following table summarizes our stock option activity for the nine months ended September 30, 2019:

  

                   

Weighted

         
           

Weighted

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
   

Number of

   

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term (in years)

   

Value

 

Outstanding at December 31, 2018

    2,040,000     $ 0.47       6.63       -  

Granted

    -       -       -       -  

Exercised

    -       -       -       -  

Cancelled

    (900,000 )     0.63       -       -  

Forfeited or expired

    -       -       -       -  

Outstanding at September 30, 2019

    1,140,000     $ 0.35       6.50       -  
                                 

Exercisable at September 30, 2019

    680,000     $ 0.43       4.89     $ -  

 

At September 30, 2019, 680,000 stock options were exercisable and $47,191 of total compensation cost related to share-based compensation grants had been recognized for the nine months ended September 30, 2019. Unrecognized compensation expense from stock options was $118,409 at September 30, 2019, which is expected to be recognized over a weighted-average vesting period of 2.13 years beginning October 1, 2019.

 

There were no options granted during the nine months ended September 30, 2019.

 

A summary of the status of the Company’s nonvested options as of September 30, 2019, is presented below:

 

Nonvested options

       
   

Number of

 
   

Shares

 

Nonvested options at December 31, 2018

    690,000  

Granted

    -  

Exercised

    -  

Cancelled

    -  

Forfeited or expired

    -  

Vested

    (230,000 )

Nonvested options at September 30, 2019

    460,000  

 

9

 
 

Note 6: Concentrations 

 

We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune 500 companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the nine months ended September 30, 2019 and 2018, the percentage of sales and the concentrations are:

 

   

2019

   

2018

 

Largest client

    20 %     41 %

Second largest client

    20 %     20 %

Third largest client

    14 %     16 %

Next three largest clients

    26 %     18 %

All other clients

    20 %     5 %
      100 %     100 %

 

Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is no provision made to include an allowance for doubtful accounts.

   

 

Note 7: Going Concern

 

The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.

 

We have had material operating losses and have not yet created positive cash flows for a full year. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to increase our net operating income. In an effort to reduce operating losses and generate positive cash flow, we have initiated cost containment plans that include but are not limited to an agreement with the Interim Chief Executive Officer that he will not take any cash compensation from the Company until such time that he and the Board mutually determine.  We continue to focus on our sales pipeline of new business and our cost reduction plans to improve upon our positive working capital of $1,063,401 at September 30, 2019.  These measures combined with our positive working capital position should enable us to meet our liquidity needs over the next 12 months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

 

 

Note 8: Basic and Diluted Net Income / (Loss) per Share

 

Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the three and nine months ended September 30, 2019 and 2018, the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income / (loss) per share basic and diluted are equal in all periods presented. Securities that were not included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of 680,000 and 1,350,000 for the three and nine months ended September 30, 2019 and 2018, respectively.

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2019

   

2018

   

2019

   

2018

 

Net loss

  $ (524,453 )   $ (254,176 )   $ (434,492 )   $ (308,962 )

Basic and diluted weighted average

                               

common shares outstanding

    20,426,158       20,426,158       20,426,158       20,426,158  
                                 

Net loss per share, basic and diluted

  $ (0.03 )   $ (0.01 )   $ (0.02 )   $ (0.02 )

 

10

 

 

 

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Cautionary Statement

 

This Management’s Discussion and Analysis includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: “believe,” “expect,” “plan”, “estimate,” “anticipate,” “intend,” “project,” “will,” “predicts,” “seeks,” “may,” “would,” “could,” “potential,” “continue,” “ongoing,” “should” and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this Form 10-Q. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or from our predictions. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

 

Unless the context otherwise requires, all references to "McorpCX," "we," "us," "our" or the "Company" are to McorpCX, Inc. and our subsidiaries.

 

Critical Accounting Policies and Estimates

 

Our financial statements are prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates. We believe that the assumptions and estimates associated with revenue recognition, income taxes, stock-based compensation, research and development costs and impairment of long-lived assets have the greatest potential impact on our financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

 

A description of the Company’s critical accounting policies and related judgments and estimates that affect the preparation of the Company’s financial statements is set forth in under the heading “Critical Accounting Policies and Estimates” in Item 7, Management’s Discussion and Analysis of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. With the exception of the policy adoptions discussed in Note 2 of the Notes to the Consolidated Financial Statements included with this report, such policies were unchanged during the nine months ended September 30, 2019.

 

Overview

 

We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. We believe that delivering better customer experiences is a powerful, sustainable way for any organization to differentiate themselves from their competition. As such, we are engaged in the business of providing customer experience focused consulting services and where applicable, delivering technology-enabled services that are designed to help corporations improve their customer listening and customer experience management capabilities with the goal of helping them design and deliver better experiences for their customers.

 

Our primary source of revenue is derived from our consulting services which are intended to help primarily large and medium sized organizations plan, design and deliver better customer experiences in order to maximize their return on investment, improve efficiency, and increase the adoption of our products and services. Our services offered include a range of customer experience management consulting services in the areas of research, strategy development, planning, education, training and best practices, as well as providing customer-centric strategies and implementation roadmaps in support of these strategies.

 

We have developed on-demand “cloud based” customer experience management software such as Touchpoint Mapping® On-Demand (also marketed as McorpCX | Insights), referred to as “Touchpoint Mapping”, and McorpCX | Persona.

 

Touchpoint Mapping is a research-based online Software-as-a-Service (“SaaS”) solution designed to provide insights to organizations that can help them improve customer and employee experience, brand, and loyalty. It is designed to be a solution for customer-centric organizations to measure and gather customer data across all their touchpoints, channels and interactions with their customers.

 

McorpCX | Persona, another online SaaS solution, is designed for developing and managing customer persona, as well as automating the currently manual process of developing, managing and sharing persona across corporations. It is designed to help customer-centric businesses and the agencies and consultancies that serve them to better understand, connect with and serve their customers.

 

There are many potential unforeseen and significant market and competitive risks associated with our current products and services. Though we released the first version of Touchpoint Mapping in 2013, and we released the first version of McorpCX | Persona in 2016, neither product has generated significant sales revenue to date, and we cannot predict the timing or probability of generating material sales revenue from either of them. Further, as of the date of this report, we have yet to engage the necessary development, client support, and sales staff required to identify, develop, and close material product sales opportunities that we believe are required to achieve our product sales and revenue growth objectives. We also believe that our current software capabilities are more limited in scope than our desired final software platform and as such, significant further software development expenditures will be required, which at this time the Company is not prepared to make. Consequently, during the second half of 2017 we stopped further development of our software products, and in 2018 we suspended actively selling Touchpoint Mapping and McorpCX | Persona until we more fully assess the roadmap to make these products more marketable to clients. As a result, revenues from our consulting services provided to our clients represented a majority of our revenue in 2018 and for the nine months ended September 30, 2019, and management believes that consulting services will remain our most significant revenue source for the foreseeable future.

 

11

 

 

Although management still believes that offering technology enabled consulting services can provide long-term profitability and we intend to continue to explore ways to successfully commercialize our software products, in both the short-term and mid-term, we are focused on expanding our consulting business which we believe may lead to greater revenues for the Company and which could be utilized for cross sale of technology products to our consulting clients. We intend to continue to evaluate our software products to determine the next phase of new product development and potential enhancements to our existing product suite or to identify other software products that may be more conducive to supporting our CX consulting expertise.

 

The Company is in the process of determining the optimal path forward for our software products based on current market dynamics, the competitive environment and customer feedback. We continue to evaluate various potential strategies with the goal of improving our ability to achieve additional revenue and profit growth for both our software products as well as our consultant services. These possible strategies, which are generally focused on ways to create a more complete slate of customer experience solutions for our clients, include further software or technology development expenditures, pursuit of merger, acquisitions or joint ventures with companies that provide complimentary products and services, software licensing arrangements, and investment in additional infrastructure within our Company. Each of these possible strategies will be thoroughly vetted by our board of directors to assess the expected level of enterprise value creation for each strategy compared to the various risks associated with each possible scenario. In addition, we may require financing to pursue these strategies that is beyond our current financial resources. Accordingly, there is no assurance that we will be able to pursue any strategies that are identified by our board of directors.

 

We cannot assure you that we will be able to compete successfully against current or potential competitors, or that competition will not have a material adverse effect on our business, financial condition and operations. 

 

Summary of Financial Results

 

Select financial highlights for the three and nine months ended September 30, 2019:

 

 

Total revenue decreased by 51% from $933,836 during the third quarter of 2018 to $453,226 during the third quarter of 2019, and decreased by 11% from $2,952,344 during the first nine months of 2018 to $2,640,664 during the first nine months of 2019.

     
 

Gross profit decreased by 65% from $311,408 in the third quarter of 2018 to $109,364, in the third quarter of 2019, but increased by 14% from $1,291,712 in the first nine months of 2018 to $1,470,236 in the first nine months of 2019.

 

 

We recorded net loss of $524,453 in the third quarter of 2019, compared to net loss of $254,176 for the third quarter of 2018. Net loss was $434,492 in the first nine months of 2019 compared to a net loss of $308,962 for the first nine months of 2018.

 

 

 

 

The Company reported EBITDA(1) of $(503,586) and $(333,464) in the third quarter and first nine months of 2019, respectively, compared to an EBITDA of  $(204,478) and $(154,840) and in the third quarter and first nine months of 2018, respectively.

 

 

 

 

The Company had a cash balance of $769,145 at September 30, 2019 compared to a cash balance of $1,350,014 at December 31, 2018.

 

(1) We define EBITDA as net income (loss) plus interest, tax, depreciation and amortization expenses. We consider EBITDA to be a meaningful supplement to net income (loss) as a performance measure primarily because depreciation and amortization expenses are not actual cash costs, and interest and tax expenses are not related to our direct operating activities. See page 15 for a reconciliation of net income (loss) to EBITDA.

 

Sources of Revenue

 

Our revenue consists primarily of fees from professional and consulting services and other revenue primarily related to the reimbursement of expenses. Through May 31 of this year, revenue was also derived from software-enabled product sales. Consulting services include customer experience management consulting in the areas of strategy development, planning, education, training and program design, and includes the articulation of customer-centric strategies and implementation roadmaps in support of these strategies, while other revenue includes reimbursement of related travel costs and out-of-pocket expenses. Product revenue was from productized and software-enabled service sales not elsewhere classified.

 

The consulting services are contracted under master terms and conditions with statements of work (“SOW”) defined for each project. A typical consulting SOW will span a period of 60-180 days and will usually be billed to the client based on certain milestones being achieved throughout the SOW. The Company recognizes revenue based upon a percentage of completion of each SOW during each project. In addition, we typically incur travel and other miscellaneous expenses during work on each SOW which we bill to our clients for reimbursement. The travel and miscellaneous expenses are recognized in revenue on a percentage of work complete basis.

 

We anticipate that fees for professional and consulting services will remain our most significant revenue source in the foreseeable future. We have not obtained material stand-alone sales commitments for Touchpoint Mapping or McorpCX | Persona, and do not anticipate being able to do so until we engage the necessary development, product support, and sales and marketing staff to further develop our software products and execute product sales opportunities. During the second half of 2017, we stopped further development of our software products and in 2018 we suspended actively selling Touchpoint Mapping and McorpCX | Persona in order to re-assess the product roadmap to better define the future direction of our software platform. On May 31, 2019, the last remaining contract for Touchpoint Mapping was closed, and we believe no further revenue will be recognized from this date, unless we decide to resume actively selling our software products and obtain material stand-alone sales commitments for them.

 

Subscription agreements for our software solutions have been offered as monthly term agreements which contain a minimum commitment period of at least 12 months, and which have included related setup, upgrades, hosting and support. Professional services have included consulting fees related to implementation, customization, configuration, training and other services.

 

12

 

 

When we were actively selling the products, we found that the implementation stage of on-demand software and software-enabled services engagements (the time between a client placing an order to the live deployment of our product ordered) averaged between 30 and 45 days. We typically invoiced clients upon inception of subscription agreements for setup and total subscription fees contracted over the term of the agreements, with payment due within 30 days. We then recognized the subscription fee revenue, including any associated professional services or separate set-up fee revenue, on a straight-line basis over the life of the agreement.

 

Professional services related to the subscription agreements are invoiced at the inception of the professional services agreement at a negotiated percentage of total fees, often but not exclusively one-third or one-half of the total estimated professional services fees, with the balance of payments due over the duration of the contract as project milestones are met. Amounts invoiced are recorded in accounts receivable and deferred revenue or revenue, depending on whether revenue recognition criteria have been met.

 

Cost of Goods Sold and General and Administrative Expenses

 

Cost of Goods Sold

 

Cost of goods sold has historically consisted primarily of expenses directly related to providing professional and consulting services. Those expenses include contract labor, third-party services, and materials and travel expenses related to providing professional services to our clients. Costs of goods also includes, but is not limited to, product-related hosting and monitoring costs, the cost of licenses for products embedded in the application, amortization of capitalized software development costs, service support costs, and costs related to account and subscription management, as applicable.

 

Should our client base grow, we intend to continue to invest additional resources in our hosting, technical support and professional services capabilities, as well as our utilization of third-party licensed software.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of salary and related expenses for management, client delivery, finance and accounting, and sales and marketing. These expenses also include contract services, as well as marketing and promotion costs, professional fees, software license fee expenses, administrative costs, insurance, rent and a portion of travel expenses and other overhead, which are categorized as “other general and administrative expenses” in our consolidated financial statements. In addition, the other general and administrative expenses include the professional fees, filing, and registration costs necessary to meet the requirements associated with having to file reports with the United States Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as well as having our stock listed on the TSX Venture Exchange in Canada and quoted on the OTCQB venture marketplace in the United States.

 

Sales and marketing expenses are currently reflected in salaries and wages, commissions, contract labor, sales, marketing and promotion, and other related overhead expense categories. Since we currently recognize revenue over the term of the consulting and professional services engagements or any software subscriptions, we expect to experience a delay between increases in selling and marketing expenses and the recognition of revenue. We expect to continue to incur significant sales and marketing expenses in both absolute dollars and as a percentage of expenses as we seek to increase the level of our sales and marketing activities. We expect that total general and administrative expenses will increase as we continue to add resources in connection with the growth of our business.

 

Results of Operations

 

                   

Change from

   

Percent Change

 

Revenue

 

2019

   

2018

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 453,226     $ 933,836     $ (480,610 )     (51% )

Nine Months Ended September 30,

  $ 2,640,664     $ 2,952,344     $ (311,680 )     (11% )

 

Overall, the 51% decrease in revenue for the three months ended September 30, 2019 compared to the three months ended September 30, 2018 was attributed to a 48% decrease in consulting services revenue and 68% decrease in products and other revenue for the three months ended September 30, 2019 compared to the same quarter in 2018. The decrease in consulting services revenue from $772,081 in the third quarter of 2018 to $401,318 for the three months ended September 30, 2019 was primarily the result of the scope of consulting projects worked on by the Company during the third quarter of 2019 being less than the scope of the consulting projects worked on in the same quarter of 2018. Additionally, consulting services revenues were reduced by $43,966 in the third quarter of 2019 as a result of actual expense reimbursement revenue being less than the forecast expense reimbursement revenue that had previously been recognized by the Company. The decrease in products and other revenue from $161,755 in the third quarter of 2018 to $51,908 for the three months ended September 30, 2019 was primarily the result of our decision to suspend selling each of our software products in 2018 combined with a decrease in reimbursable expense income during the current quarter compared to the same quarter of 2018. 

 

Overall, the 11% decrease in revenue for the first nine months of 2019 compared to the first nine months of 2018 was primarily attributed to a 63% decrease in product and other revenue for the nine months ended September 30, 2019 compared to the same period in 2018. The decrease in product and other revenue from $385,191 to $143,581 for the nine months ended September 30, 2018 and 2019, respectively, was primarily the result of our decision to suspend selling each of our software products in 2018 combined with a decrease in reimbursable expense mostly resulting from less travel required to execute the projects during the first nine months of 2019 compared to the same period in 2018.  There was also a slight decrease of 3% in consulting services revenue for the nine months ended September 30, 2019 compared to the same period in 2018. The decrease in consulting services revenue from $2,567,153 in the first nine months of 2018 to $2,497,083 for the nine months ended September 30, 2019 was primarily the result of increased consulting services revenue in the first half of 2019 being more than offset by decreased consulting services revenue in the third quarter for the reasons discussed above.

 

13

 

 

                   

Change from

   

Percent Change

 

Cost of Goods Sold

 

2019

   

2018

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 343,862     $ 622,428     $ (278,566 )     (45% )

Nine Months Ended September 30,

  $ 1,170,428     $ 1,660,632     $ (490,204 )     (30% )

 

Cost of goods sold decreased by $278,566 for the three months ended September 30, 2019, compared to the same period in 2018 primarily as a result of a 25% decrease in professional fees and a 85% decrease in reimbursable expenses during the current quarter compared to the same quarter of 2018. The decrease in professional fee costs from $407,421 in the third quarter of 2018 to $304,634 for the three months ended September 30, 2019 was primarily the result of a decrease in billings from our contract consultants used to support our consulting services mostly due to reduced consulting services provided to clients during the current quarter compared to the same quarter of 2018. The decrease in reimbursable expenses from $153,896 in the third quarter of 2018 to $23,064 for the three months ended September 30, 2019 was primarily the result of less contracts and lower requirements for travel and other reimbursable costs on those contracts. 

 

Cost of goods sold decreased by $490,204 for the nine months ended September 30, 2019, compared to the same period in 2018 primarily as a result of 20% decrease in professional fees and 64% decrease in reimbursable expenses during the first nine months of 2019 compared to the same period on 2018. The decrease in professional fees from $1,120,502 in the first nine months of 2018 to $900,290 for the nine months ended September 30, 2019 was primarily the result of a decrease in billings from our contract consultants due to less consulting revenue volume described above. The decrease in reimbursable expenses from $344,903 in the first nine months of 2018 to $123,095 for the nine months ended September 30, 2019 was primarily the result of reduction in reimbursable research costs required under the specific contracts.

 

 

                   

Change from

   

Percent Change

 

Net Operating Income (Loss)

 

2019

   

2018

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ (517,571 )   $ (249,756 )   $ (267,815 )     107 %

Nine Months Ended September 30,

  $ (423,537 )   $ (303,382 )   $ (120,155 )     (40% )

 

For the three months ended September 30, 2019 we had net operating loss of $517,571 compared to a net operating loss of $249,756 for the three months ended September 30, 2018. The increase in net operating loss in the current quarter was primarily a result of decreased total revenues, and an increase in general and administrative costs being partially offset by decrease in costs of goods sold when compared to the same period in 2018.

 

For the three months ended September 30, 2019 we had net loss of $524,453 compared to a net loss of $254,176 for the three months ended September 30, 2018, and EBITDA decreased by $299,108 to a loss of $503,586 for the three months ended September 30, 2019 compared to a loss of $204,478 for the three months ended September 30, 2018.

 

For the nine months ended September 30, 2019 we had net operating loss of $423,537 compared to a net operating loss of $303,382 for the nine months ended September 30, 2018. The increase in net operating loss in the first nine months of 2019 was primarily a result of decreased total revenues, and an increase in general and administrative costs being partially offset by decrease in costs of goods sold when compared to the same period in 2018.

 

For the nine months ended September 30, 2019 we had net loss of $434,492 compared to a net loss of $308,962 for the nine months ended September 30, 2018, and EBITDA decreased by $178,624 to a loss of $333,464 for the nine months ended September 30, 2019 compared to loss of $154,840 for the nine months ended September 30, 2018.

 

14

 

 

The following table provides a reconciliation of net income (loss) to EBITDA for the periods indicated:

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2019

   

2018

   

2019

   

2018

 
                                 

Net Loss

  $ (524,453 )   $ (254,176 )   $ (434,492 )   $ (308,962 )

Depreciation and Amortization

    20,384       49,053       98,790       153,074  

Interest expense

    483       645       2,238       1,048  
                                 

EBITDA

  $ (503,586 )   $ (204,478 )   $ (333,464 )   $ (154,840 )

 

                   

Change from

   

Percent Change

 

Salaries and Wages

 

2019

   

2018

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 282,883     $ 251,111     $ 31,772       13 %

Nine Months Ended September 30,

  $ 870,813     $ 684,029     $ 186,784       27 %

 

Salaries and wages increased by $31,772 during the three months ended September 30, 2019 compared to the same period in 2018 primarily due to an increase in the number of executives in the current quarter compared to the same quarter in 2018.

 

Salaries and wages increased by $186,784 during the nine months ended September 30, 2019 compared to the same period in 2018 primarily due to increase executive salaries from an increase in the number of executive officers in connection with our corporate restructuring in August 2018.

 

We did not incur any software development costs for the three and nine months ended September 30, 2019 primarily due to the decision to curtail additional software development halfway through 2017.

 

                   

Change from

   

Percent Change

 

Contract Services

 

2019

   

2018

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 54,590     $ 47,202     $ 7,388       16 %

Nine Months Ended September 30,

  $ 126,928     $ 161,453     $ (34,525 )     (21% )

 

Contract services for the three months ended September 30, 2019 increased compared to the same period in the prior year primarily due to an increase in marketing costs, being partially offset by a decrease in corporate and investor relations costs in the current quarter compared to the same quarter in 2018. Contract services expenses decreased during the nine months ended September 30, 2019 compared to the same periods in 2018 primarily due to finance and administration services provided by contractors in the first nine months of 2018, which were not required in the first nine months of 2019.

 

                   

Change from

   

Percent Change

 

Other General and Administrative

 

2019

   

2018

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ 289,462     $ 262,851     $ 26,611       10 %

Nine Months Ended September 30,

  $ 896,032     $ 749,612     $ 146,420       20 %

 

Other general and administrative costs increased $26,611 and $146,420 during the three and nine months ended September 30, 2019, respectively, compared to the same periods in 2018, primarily due to increases in computers and software and travel expenses being partially offset by decreases in professional fees, rent, and marketing and promotion costs.

  

                   

Change from

   

Percent Change

 

Other Income (Expense), net

 

2019

   

2018

   

Prior Year

   

from Prior Year

 

Three Months Ended September 30,

  $ (6,399 )   $ (3,775 )   $ (2,624 )     70 %

Nine Months Ended September 30,

  $ (8,717 )   $ (4,532 )   $ (4,185 )     92 %

 

Other expense increased for the three months ended September 30, 2019 compared to the third quarter of 2018, primarily due to increased state use tax expenses in the current quarter compared to the same quarter of 2018.

 

Other expense increased for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to increased state use tax expenses in the current quarter compared to the same period of 2018.

 

15

 

 

Liquidity and Capital Resources

 

We measure our liquidity in a variety of ways, including the following:

 

   

September 30,

   

December 31,

 
   

2019

   

2018

 

Cash and cash equivalents

  $ 769,145     $ 1,350,014  

Working capital

  $ 1,063,401     $ 1,348,700  

 

 

Anticipated Uses of Cash

 

For the nine months ended September 30, 2019 and the year ended December 31, 2018, we were able to finance our operations with cash generated through operating activities, and cash on hand. The accompanying consolidated financial statements have been prepared in accordance with GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

 

In 2018, our primary area of investment was professional staff to support our consulting services, including client relationship management, software maintenance costs during the first nine months of 2018 and staff for administration, sales and marketing activities.

 

During the nine months ended September 30, 2019, our primary uses of cash included cash paid to professional staff to support our consulting services, general and administrative support and new business development activities. We implemented plans at the start of 2019 with the goal of growing our sales pipeline to create more consistency in our revenues which required a greater level of expenses associated with the cost of sales and marketing.  We plan to continue to focus on sales pipeline growth so that we can more reliably hire lower cost employees versus utilizing independent contractors to execute upon our consulting projects. 

 

We currently plan to fund our expenditures with cash flows generated from ongoing operations and/or if needed, the possibility may exist to raise additional capital through debt financing and/or through sales of common stock. We do not intend to pay dividends in the foreseeable future. Based upon the current level of our pipeline of signed contracts and pipeline of potential new projects plus our current expectations for future periods in light of the current economic environment, we believe that cash flow from operations and available cash will be adequate to finance the capital requirements for our business during the next 12 months.

 

We continue to seek ways to expand upon our business and as such, in the future we may make acquisitions of businesses or assets or commitments to additional capital projects. To achieve the long-term goals of expanding our assets and earnings, including through acquisitions, capital resources may be required. Depending on the size of a transaction, the capital resources that may be required can be substantial. The necessary resources may be generated from cash flow from operations, cash on hand, borrowing against our assets or the issuance of securities, and there is no assurance these capital resources will be available to us when required.

 

Cash Flow – Nine months Ended September 30, 2019 and 2018

 

Operating Activities. Net cash used in operating activities increased to $580,869 for the nine months ended September 30, 2019 compared to net cash used in operating activities of $133,512 for the nine months ended September 30, 2018. This increase in cash used in 2019 was primarily due to decreased accounts payable and accrued liabilities, combined with an increase in net loss of $125,530 in the first nine months of 2019 compared to the same period in 2018.

 

Days Sales Outstanding (“DSO”), which the Company defines as the average number of days it takes to collect revenue once a sale has been made, increased in the first nine months of 2019 compared to the same period of the prior year. During the nine months ended September 30, 2019, DSO was approximately 58 days, up from approximately 45 days during nine months ended September, 2018. This increase was largely attributed to the increase in accounts receivable and decrease in sales during the current period. DSO can fluctuate due to the timing and nature of contracts that lead to up-front billings related to deferred revenue on services not yet performed.

 

Investing Activities. There was no cash provided by, or used in, investing activities for nine months ended September 30, 2019. There was $4,474 net cash used in investing activities for the nine months ended September 30, 2018.

 

Financing Activities. There was no cash provided by, or used in, financing activities for the nine months ended September 30, 2019. Net cash used in financing activities for nine months ended September 30, 2018 amounted to $8,169 which related to the repayment of a $100,000 CAD note during the period.  

 

Off Balance Sheet Arrangements

 

We did not have any off-balance sheet arrangements as of September 30, 2019.

  

16

 

   

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

  

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and as such, are not required to provide the associated information under this item.

 

  

ITEM 4.

CONTROLS AND PROCEDURES.

 

Disclosure Controls and Procedure

 

Pursuant to Rule 13a-15(b) and Rule 15d-15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s management concluded that, as of the period covered by this report, the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

 

It should be noted that any system of controls is based in part upon certain assumptions designed to obtain reasonable (and not absolute) assurance as to its effectiveness, and there can be no assurance that any design will succeed in achieving its stated goals.

 

 

 

 

Changes in Internal Controls

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II. OTHER INFORMATION

 

 

ITEM 1.

LEGAL PROCEEDINGS.

 

We are not involved in any legal actions or claims and to our knowledge no such actions or claims are pending.

  

 

ITEM 1A.

RISK FACTORS.

 

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Annual Report”), which could materially affect our business, results of operations or financial condition.

 

The risk factors affecting the Company have not materially changed as of September 30, 2019 from those disclosed in the 2018 Annual Report. However, it is important to note that the risks described in our 2018 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may eventually prove to materially adversely affect our business, results of operations or financial condition.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Recent Sales of Unregistered Securities

 

There were no unregistered sales of our equity securities during the nine-month period ended on September 30, 2019.

 

Purchases of Equity Securities

 

During the nine months ended September 30, 2019, there were no purchases of our common stock made by, or on behalf of, the Company or any "affiliated purchaser," as defined by Rule 10b-18 of the Exchange Act.

  

17

 

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

  

ITEM 4.

MINE SAFETY DISCLOSURES

 

Not applicable.

  

 

ITEM 5.

OTHER INFORMATION.

 

(a)

Not applicable.

  

18

 

 

ITEM 6.

EXHIBITS. 

 

3.1

Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.2

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.3

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.4

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).

3.5

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).

3.6 

Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).

31.1

Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).

31.2

Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).

32.1*

Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

32.2*

Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

 

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension – Schema

101.CAL

XBRL Taxonomy Extension – Calculations

101.DEF

XBRL Taxonomy Extension – Definitions

101.LAB

XBRL Taxonomy Extension – Labels

101.PRE

XBRL Taxonomy Extension – Presentation

 

*Furnished, not filed

 

Notes to Exhibits List:

 

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Balance Sheet, (ii) Statements of Operations, (iii) Statements of Cash Flows, and (iv)Notes to the Financial Statements. In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

19

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report has been signed on its behalf by the undersigned, thereunto duly authorized on this 14th day of November 2019.

 

 

MCORPCX, INC.

 

 

 

 

 

BY:

/s/ Gregg Budoi

 

 

Gregg Budoi

 

 

Chief Executive Officer

  

  

  

  

BY:

/s/ Tricia Tomko

  

 

Tricia Tomko

  

 

Chief Financial Officer

 

20

 

 

EXHIBIT INDEX

 

3.1

Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.2

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.3

Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).

3.4

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).

3.5

Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).

3.6 

Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).

31.1

Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).

31.2

Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).

32.1*

Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

32.2*

Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

 

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension - Schema

101.CAL

XBRL Taxonomy Extension - Calculations

101.DEF

XBRL Taxonomy Extension - Definitions

101.LAB

XBRL Taxonomy Extension - Labels

101.PRE

XBRL Taxonomy Extension - Presentation

 

*Furnished, not filed

 

Notes to Exhibits List:

 

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Balance Sheet, (ii) Statements of Operations, (iii) Statements of Cash Flows, and (iv)Notes to the Financial Statements. In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

21

EX-31.1 2 ex_163887.htm EXHIBIT 31.1 ex_163887.htm

Exhibit 31.1

 

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

 

I, Gregg Budoi, certify that:

 

1.

I have reviewed this Form 10-Q for the quarterly period ended September 30, 2019 of McorpCX, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

  

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

   

  

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

   

  

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

   

  

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

   

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

  

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

   

  

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:

November 14, 2019

/s/ Gregg Budoi

  

 

Gregg Budoi

  

 

Chief Executive Officer

 

EX-31.2 3 ex_163888.htm EXHIBIT 31.2 ex_163888.htm

Exhibit 31.2

 

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

 

I, Tricia Tomko, certify that:

 

1.

I have reviewed this Form 10-Q for the quarterly period ended September 30, 2019 of McorpCX, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

  

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

   

  

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

   

  

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

   

  

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

   

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

  

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

   

  

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:

November 14, 2019

/s/ Tricia Tomko

  

 

Tricia Tomko

  

 

Chief Financial Officer

 

EX-32.1 4 ex_163889.htm EXHIBIT 32.1 ex_163889.htm

Exhibit 32.1

 

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of McorpCX, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregg Budoi, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     

  

(2)

The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated this 14th day of November, 2019.

 

 

  

/s/ Gregg Budoi

  

Gregg Budoi

  

Chief Executive Officer

EX-32.2 5 ex_163890.htm EXHIBIT 32.2 ex_163890.htm

Exhibit 32.2

 

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of McorpCX, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tricia Tomko, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     

  

(2)

The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated this 14th day of November, 2019.

 

 

  

/s/ Tricia Tomko

  

Tricia Tomko

  

Chief Financial Officer

EX-101.INS 6 mccx-20190930.xml XBRL INSTANCE DOCUMENT false --12-31 Q3 2019 2019-09-30 10-Q 0001535079 20426158 Yes false Non-accelerated Filer McorpCX, Inc. false true P3Y -21083 20498 1063401 157596 220576 565470 343036 6501982 6454791 3087 3087 2781 2781 4981 4981 15558 15558 15730 15730 15903 15903 47191 0 680000 1350000 1504531 1964968 1334615 1693050 0 0 0 0 19753 48458 96898 145375 12070 108968 1350014 1616076 769145 1469921 -580869 -146155 0 0 500000000 500000000 20426158 20426158 20426158 20426158 20426158 20426158 20426158 20426158 20426158 20426158 20426158 20426158 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6:</div> Concentrations</div><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500</div> companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the percentage of sales and the concentrations are:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Second largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Third largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Next three largest clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">All other clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> provision made to include an allowance for doubtful accounts.</div></div> 0.2 0.41 0.2 0.2 0.14 0.16 0.26 0.18 0.2 0.05 1 1 97187 122238 122238 80057 0 0 304634 407421 900290 1120502 39228 215007 270138 540130 343862 622428 1170428 1660632 98790 153074 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5:</div> Stock-Based Compensation</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Our stock-based compensation plan was originally established in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2008.</div> The shares of our common stock issuable pursuant to the terms of such plan (the &#x201c;Plan Shares&#x201d;) could <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> exceed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> of any outstanding issue or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500,000</div> shares, whichever was the lower amount.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2015, </div>we adopted a revised share option plan in which Plan Shares cannot exceed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-year term. This share option plan was approved by the Company&#x2019;s shareholders at the annual meeting of shareholders on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 10, 2016.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110.</div> The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The following table summarizes our stock option activity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Weighted</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Remaining</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Aggregate</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Number of</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Exercise</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Contractual</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Intrinsic</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Shares</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Price</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Term (in years)</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Value</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,040,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cancelled</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(900,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at September 30, 2019</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,140,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at September 30, 2019</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.43</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.89</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,000</div> stock options were exercisable and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$47,191</div> of total compensation cost related to share-based compensation grants had been recognized for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019. </div>Unrecognized compensation expense from stock options was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$118,409</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>which is expected to be recognized over a weighted-average vesting period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.13</div> years beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> options granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">A summary of the status of the Company&#x2019;s nonvested options as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>is presented below:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Nonvested options</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Nonvested options at December 31, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">690,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cancelled</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(230,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Nonvested options at September 30, 2019</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">460,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div></div> -0.03 -0.01 -0.02 -0.02 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8:</div></div> <div style="display: inline; font-weight: bold;">Basic and Diluted Net Income / (Loss) per Share</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share &#x2013; basic and diluted. The share options were anti-dilutive due to the Company&#x2019;s net loss or the Company&#x2019;s common stock average market price was less than the share options exercise price. Accordingly, net income / (loss) per share basic and diluted are equal in all periods presented. Securities that were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,350,000</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(524,453</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(254,176</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(434,492</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(308,962</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic and diluted weighted average</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">common shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss per share, basic and diluted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div></div> P2Y47D 118409 289462 262851 896032 749612 109364 311408 1470236 1291712 -62980 263584 222434 207134 -25051 -11714 146 2150 -18546 35359 483 645 2238 1048 2238 1048 271214 344350 1504531 1964968 271214 344350 -8169 -4474 -580869 -133512 -434492 -308962 -524453 -254176 -202716 -202716 147930 147930 -254176 4777 4777 85184 85184 -524453 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2:</div> Recent Accounting Pronouncements</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the Financial Accounting Standard Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02&#x201d;</div>) to increase the transparency and comparability about leases among entities. Additional ASUs have been issued subsequent to ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> to provide supplementary clarification and implementation guidance for leases related to, among other things, the application of certain practical expedients, the rate implicit in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> and these additional ASUs are now codified as Accounting Standards Codification Standard <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> - &#x201c;Leases&#x201d; (&#x201c;ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842&#x201d;</div>). ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> supersedes the lease accounting guidance in Accounting Standards Codification <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840</div> &#x201c;Leases&#x201d; (&#x201c;ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840&#x201d;</div>) and requires lessees to recognize a lease liability and a corresponding lease asset for virtually all lease contracts. It also requires additional disclosures about leasing arrangements. The Company&#x2019;s consolidated financial statements for the periods prior to the adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> adjusted and are reported in accordance with the Company&#x2019;s historical accounting policy. As of the date of implementation on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019, </div>the impact of the adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div> resulted in the recognition of a right of use asset, included in other assets, and lease payable obligation on the Company&#x2019;s consolidated balance sheets of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$34,000</div>.</div> We elected the package of practical expedients permitted under the transition guidance.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As the right of use asset and the lease payable obligation were the same upon adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842,</div> there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> cumulative effect impact on the Company&#x2019;s retained earnings.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">220,</div> Income Statement &#x2014; Reporting Comprehensive Income, to &#x201c;allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.&#x201d; In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>and interim periods within those fiscal years. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019. </div>The adoption of this standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div></div> 626935 561164 1893773 1595094 -517571 -249756 -423537 -303382 34000 14749 34000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1:</div> Organization and Basis of Presentation</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">McorpCX, Inc. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; or the &#x201c;Company&#x201d;&#x201d;) was incorporated in the State of California on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 14, 2001. </div>We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 18, 2011. </div>During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Q1</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 11, 2015, </div>at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company formed a wholly owned subsidiary, McorpCX, LLC (&#x201c;McorpCX LLC&#x201d;) as a limited liability company in the state of Delaware on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 14, 2017. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 16, 2018, </div>the Company entered into a contribution agreement with its wholly owned subsidiary McorpCX LLC, pursuant to which the Company transferred to McorpCX LLC all of the Company&#x2019;s assets and liabilities related to the Company&#x2019;s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand &#x201c;cloud based&#x201d; customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization.&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated financial statements and related disclosures as of and for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>was derived from the audited consolidated financial statements included in our Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018. </div>Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>filed on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K with the SEC on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 1, 2019.&nbsp; </div>The results of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results to be expected for the full year.</div></div> 69664 72876 1682 1536 -6399 -3775 -8717 -4532 4474 54590 47202 126928 161453 88182 90074 8169 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4:</div> Capitalized Software Development Costs</div>&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> capitalizable costs during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-year expected useful life of the software. Capitalized software development costs, net of amortization, were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12,070</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$108,968</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>respectively. Amortization expense incurred during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,753</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$48,458,</div> respectively, and during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$96,898</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$145,375,</div> respectively, and is included in cost of goods sold in the consolidated statements of operations.</div></div> -5268665 -4834173 401318 772081 2497083 2567153 51908 161755 143581 385191 453226 933836 2640664 2952344 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div>&nbsp;Revenues</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Consulting Service Revenues</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company&#x2019;s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the analysis of a client customer&#x2019;s experience. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Product and other revenue</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Product and other revenue during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue. The product related portion of this revenue originates from the utilization of the Company&#x2019;s web-hosted Touchpoint Mapping On-Demand application (&#x201c;Touchpoint Mapping&#x201d;), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services. Customer licenses for Touchpoint Mapping are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> subject to the licensing guidance in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> because the customer can&#x2019;t take possession of the software at any time and the customer would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be able to operate the software on its own or with another <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party. Fees charged to customers of Touchpoint Mapping <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company&#x2019;s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> unbundle such services into separate performance obligations as their pattern of transfer does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> differ.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Deferred Revenues (Contract Liabilities)</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company records deferred revenues when cash payments are received, including amounts which are refundable.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The aggregate amount of the fees received from customers that are allocated to each customer&#x2019;s respective performance obligation that is unsatisfied (or partially unsatisfied) is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$97,187</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and included in deferred revenue on the accompanying consolidated balance sheets. The Company expects to recognize revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$97,187</div> in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> related to these unsatisfied (or partially unsatisfied) performance obligations. Deferred revenue is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to be recognized beyond fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> we recognized revenue of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$122,238</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$80,057,</div> related to our contract liabilities included in deferred revenue at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> revenue recognized for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> related to deferred revenue balances as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Practical Expedients and Exemptions</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less and the commissions are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div></div> 97187 P1Y 34164 282883 251111 870813 684029 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="border-bottom: 1px none rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(524,453</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(254,176</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(434,492</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(308,962</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Basic and diluted weighted average</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">common shares outstanding</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,426,158</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss per share, basic and diluted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Nonvested options</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number of</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Nonvested options at December 31, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">690,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cancelled</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(230,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Nonvested options at September 30, 2019</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">460,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Weighted</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Remaining</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Aggregate</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Number of</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Exercise</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Contractual</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Intrinsic</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Shares</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Price</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Term (in years)</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Value</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2018</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,040,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.47</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cancelled</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(900,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.63</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited or expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at September 30, 2019</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,140,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.35</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.50</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at September 30, 2019</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">680,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.43</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.89</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: thin solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 66%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Second largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Third largest client</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Next three largest clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">All other clients</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">%</td> </tr> </table></div> 47191 10849 2500000 680000 0.43 900000 0 2040000 1140000 0.47 0.35 0.3 0.1 0.63 P10Y P4Y324D 690000 460000 P6Y229D P6Y182D 230000 1233317 1620618 6428997 -4422957 2006040 6432084 -4625673 1806411 6434865 -4477743 1957122 6439846 -4731919 1707927 6454791 -4834173 6470349 -4829396 1640953 6486079 -4744212 1741867 6501982 -5268665 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7:</div> Going Concern</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">We have had material operating losses and have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet created positive cash flows for a full year. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to increase our net operating income. In an effort to reduce operating losses and generate positive cash flow, we have initiated cost containment plans that include but are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to an agreement with the Interim Chief Executive Officer that he will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> take any cash compensation from the Company until such time that he and the Board mutually determine.&nbsp; We continue to focus on our sales pipeline of new business and our cost reduction plans to improve upon our positive working capital of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,063,401</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019.&nbsp; </div>These measures combined with our positive working capital position should enable us&nbsp;to meet our liquidity needs over the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.</div></div> 20426158 20426158 20426158 20426158 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0001535079 2016-08-10 2016-08-10 0001535079 us-gaap:EmployeeStockOptionMember 2016-08-10 2016-08-10 0001535079 2018-01-01 2018-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001535079 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001535079 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001535079 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:AllOtherClientsMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:LargestClientMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:NextThreeLargestClientsMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:SecondLargestClientMember 2018-01-01 2018-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:ThirdLargestClientMember 2018-01-01 2018-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2018-01-01 2018-09-30 0001535079 us-gaap:ProductMember 2018-01-01 2018-09-30 0001535079 us-gaap:ServiceMember 2018-01-01 2018-09-30 0001535079 2018-01-01 2018-12-31 0001535079 2018-04-01 2018-06-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001535079 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001535079 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001535079 2018-07-01 2018-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2018-07-01 2018-09-30 0001535079 us-gaap:ProductMember 2018-07-01 2018-09-30 0001535079 us-gaap:ServiceMember 2018-07-01 2018-09-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001535079 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001535079 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001535079 2019-01-01 2019-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001535079 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001535079 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001535079 2019-01-01 2019-09-30 0001535079 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:AllOtherClientsMember 2019-01-01 2019-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:LargestClientMember 2019-01-01 2019-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:NextThreeLargestClientsMember 2019-01-01 2019-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:SecondLargestClientMember 2019-01-01 2019-09-30 0001535079 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember mccx:ThirdLargestClientMember 2019-01-01 2019-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-09-30 0001535079 us-gaap:ProductMember 2019-01-01 2019-09-30 0001535079 us-gaap:ServiceMember 2019-01-01 2019-09-30 0001535079 2019-04-01 2019-06-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001535079 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001535079 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001535079 2019-07-01 2019-09-30 0001535079 us-gaap:ProductAndServiceOtherMember 2019-07-01 2019-09-30 0001535079 us-gaap:ProductMember 2019-07-01 2019-09-30 0001535079 us-gaap:ServiceMember 2019-07-01 2019-09-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001535079 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001535079 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001535079 2017-12-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001535079 us-gaap:CommonStockMember 2017-12-31 0001535079 us-gaap:RetainedEarningsMember 2017-12-31 0001535079 2018-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001535079 us-gaap:CommonStockMember 2018-03-31 0001535079 us-gaap:RetainedEarningsMember 2018-03-31 0001535079 2018-06-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001535079 us-gaap:CommonStockMember 2018-06-30 0001535079 us-gaap:RetainedEarningsMember 2018-06-30 0001535079 2018-09-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001535079 us-gaap:CommonStockMember 2018-09-30 0001535079 us-gaap:RetainedEarningsMember 2018-09-30 0001535079 2018-12-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001535079 us-gaap:CommonStockMember 2018-12-31 0001535079 us-gaap:RetainedEarningsMember 2018-12-31 0001535079 2019-01-01 0001535079 2019-03-31 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001535079 us-gaap:CommonStockMember 2019-03-31 0001535079 us-gaap:RetainedEarningsMember 2019-03-31 0001535079 2019-06-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001535079 us-gaap:CommonStockMember 2019-06-30 0001535079 us-gaap:RetainedEarningsMember 2019-06-30 0001535079 2019-09-30 0001535079 2019-10-01 2019-09-30 0001535079 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001535079 us-gaap:CommonStockMember 2019-09-30 0001535079 us-gaap:RetainedEarningsMember 2019-09-30 0001535079 2019-11-11 EX-101.SCH 7 mccx-20190930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Organization and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Recent Accounting Pronouncements link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Revenues link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Capitalized Software Development Costs link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Concentrations link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Going Concern link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 5 - Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 6 - Concentrations (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 2 - Recent Accounting Pronouncements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 3 - Revenues 1 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 3 - Revenues 2 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 4 - Capitalized Software Development Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 5 - Stock-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 5 - Stock-based Compensation - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 5 - Stock-based Compensation - Nonvested Options (Details) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 6 - Concentrations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 7 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share (Details Textual) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 mccx-20190930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 mccx-20190930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 mccx-20190930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual Accounts payable and accrued liabilities us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Note 5 - Stock-based Compensation Note 6 - Concentrations Contract services Additional Paid-in Capital [Member] Note 8 - Basic and Diluted Net Income (Loss) Per Share Common Stock [Member] Note 5 - Stock-based Compensation - Stock Option Activity (Details) Note 5 - Stock-based Compensation - Nonvested Options (Details) Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) Note 8 - Basic and Diluted Net Income (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Notes To Financial Statements Equity Components [Axis] Notes To Financial Statements [Abstract] Equity Component [Domain] Stock compensation expense Other assets us-gaap_LiabilitiesCurrent Total current liabilities us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period us-gaap_RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount Other current liabilities Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Expenses us-gaap_OperatingExpenses Total expenses Share-based Payment Arrangement, Activity [Table Text Block] mccx_WorkingCapital Working Capital Represents the amount of working capital as of the balance sheet date. Other general and administrative Schedule of Nonvested Share Activity [Table Text Block] Depreciation, and amortization Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Other current liabilities us-gaap_IncreaseDecreaseInOtherCurrentLiabilities Second Largest Client [Member] Represents the second largest client. Largest Client [Member] Represents the largest client. Next Three Largest Clients [Member] Represents the next three largest clients. Third Largest Client [member] Represents the third largest client. us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense All Other Clients [Member] Represents the all other clients. us-gaap_AssetsCurrent Total current assets Weighted average exercise price, options exercisable (in dollars per share) Long term assets: Weighted average remaining contractual term, options exercisable (Year) Revenue from Contract with Customer [Text Block] Options exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average remaining contractual term, outstanding balance (Year) Amendment Flag Accounting Policies [Abstract] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Vested (in shares) Concentration Risk Disclosure [Text Block] Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at September 30, 2019 and December 31, 2018 us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Nonvested options at December 31, 2018 (in shares) Nonvested options at September 30, 2019 (in shares) Adjustments to reconcile net loss to net cash used in operations: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Weighted average exercise price, outstanding balance (in dollars per share) Weighted average exercise price, outstanding balance (in dollars per share) Common stock, shares authorized (in shares) Deferred revenue us-gaap_IncreaseDecreaseInContractWithCustomerLiability Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Accounts payable and accrued liabilities Weighted average exercise price, options cancelled (in dollars per share) Common stock, shares issued (in shares) Deferred revenue Common stock, par value (in dollars per share) Weighted average exercise price, options granted (in dollars per share) Current Fiscal Year End Date Weighted average exercise price, options exercised (in dollars per share) Document Fiscal Period Focus Document Fiscal Year Focus Product and Service [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Options outstanding, balance (in shares) Options outstanding, balance (in shares) Document Period End Date ROU asset and operating lease obligation recognized upon adoption of ASU 2016-02 Product and Service [Domain] Entity Emerging Growth Company Document Type Entity Small Business us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum Entity Shell Company Interest paid us-gaap_PolicyTextBlockAbstract Accounting Policies Document Information [Line Items] Document Information [Table] Service [Member] Entity Filer Category Entity Current Reporting Status us-gaap_CapitalizedComputerSoftwareAdditions Capitalized Computer Software, Additions us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax Revenue, net Capitalized software development costs, net Capitalized Computer Software, Net, Ending Balance us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Equipment purchases Weighted average common shares outstanding-basic and diluted (in shares) Basic and diluted weighted average common shares outstanding (in shares) us-gaap_RepaymentsOfNotesPayable Repayment of notes payable us-gaap_CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization Non-cash transactions: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Customer [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Customer [Domain] Concentrations us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Product and Service, Other [Member] Net loss per share-basic and diluted (in dollars per share) Net loss per share, basic and diluted (in dollars per share) Entity Central Index Key Entity Registrant Name Liabilities: Stock based compensation - stock options Entity [Domain] Customer Concentration Risk [Member] Legal Entity [Axis] Statement [Table] Product [Member] Statement of Financial Position [Abstract] Supplemental disclosure of cash flow information: us-gaap_Assets Total assets us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Concentration Risk Type [Axis] CASH FLOWS FROM OPERATING ACTIVITIES: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition us-gaap_AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss, Ending Balance Concentration Risk Type [Domain] Statement of Cash Flows [Abstract] Statement [Line Items] Entity Common Stock, Shares Outstanding (in shares) Statement of Stockholders' Equity [Abstract] Accounts receivable Income Statement [Abstract] Revenue Benchmark [Member] Revenue, net Share-based Payment Arrangement [Text Block] us-gaap_IncreaseDecreaseInOtherNoncurrentAssets Other assets Additional paid-in capital Shareholders' equity: Concentration Risk Benchmark [Axis] Other income (expense), net Concentration Risk Benchmark [Domain] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Award Type [Domain] Current assets: mccx_CapitalizedComputerSoftwareUsefulLife Capitalized Computer Software, Useful Life The useful life of capitalized computer software. Award Type [Axis] Net loss Net loss Net loss us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Options exercised (in shares) us-gaap_TableTextBlock Notes Tables us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash used in financing activities us-gaap_Liabilities Total liabilities New Accounting Pronouncements and Changes in Accounting Principles [Text Block] us-gaap_OperatingIncomeLoss Net operating loss us-gaap_ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized Share-based Payment Arrangement, Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Decrease in cash and cash equivalents us-gaap_GrossProfit Gross profit us-gaap_CostOfGoodsAndServicesSold Cost of goods sold Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross FINANCING ACTIVITIES us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Options cancelled (in shares) Property and equipment, net us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and shareholders' equity Labor Accumulated deficit Operating lease ROU asset amortization Amount of amortization expense attributable to right-of-use asset from operating lease. Research, Development, and Computer Software Disclosure [Text Block] us-gaap_InterestExpense Interest expense mccx_IncreaseDecreaseInOperatingLeaseLiability Lease liability The increase (decrease) during the reporting period in operating lease liability. Changes in operating assets and liabilities: us-gaap_StockholdersEquity Total shareholders' equity Balance Balance Cost of goods sold us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] Class of Stock [Axis] us-gaap_OperatingLeaseLiability Operating Lease, Liability, Total Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Lease payable INVESTING ACTIVITIES us-gaap_OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset Retained Earnings [Member] Earnings Per Share [Text Block] Salaries and wages EX-101.PRE 11 mccx-20190930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Note 3 - Revenues
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]
Note
3.
 Revenues
 
Consulting Service Revenues
 
The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the analysis of a client customer’s experience. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has
no
alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.
 
Product and other revenue
  
Product and other revenue during
2018
and
2019
has primarily been derived from reimbursable expenses charged to clients and to a lesser degree from product sales and related revenue. The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services. Customer licenses for Touchpoint Mapping are
not
subject to the licensing guidance in Topic
606
because the customer can’t take possession of the software at any time and the customer would
not
be able to operate the software on its own or with another
third
party. Fees charged to customers of Touchpoint Mapping
may
include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does
not
affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do
not
unbundle such services into separate performance obligations as their pattern of transfer does
not
differ.
 
Deferred Revenues (Contract Liabilities)
 
The Company records deferred revenues when cash payments are received, including amounts which are refundable.
 
Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is
not
significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.
 
The aggregate amount of the fees received from customers that are allocated to each customer’s respective performance obligation that is unsatisfied (or partially unsatisfied) is
$97,187
as of
September 30, 2019
and included in deferred revenue on the accompanying consolidated balance sheets. The Company expects to recognize revenue of
$97,187
in
2019
related to these unsatisfied (or partially unsatisfied) performance obligations. Deferred revenue is
not
expected to be recognized beyond fiscal year
2019.
 
 
During the
nine
months ended
September 30, 2019
and
2018,
we recognized revenue of
$122,238
and
$80,057,
related to our contract liabilities included in deferred revenue at
December 31, 2018
and
2017,
respectively. There was
no
revenue recognized for the
three
months ended
September 30, 2019
and
2018
related to deferred revenue balances as of
December 31, 2018
and
2017.
 
Practical Expedients and Exemptions
 
Contract costs consist primarily of sales commissions, The Company generally expenses sales commissions when incurred because the amortization period would have been
one
year or less and the commissions are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.
 
The Company does
not
disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of
one
year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
 
XML 13 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2019
Nov. 11, 2019
Document Information [Line Items]    
Entity Registrant Name McorpCX, Inc.  
Entity Central Index Key 0001535079  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Common Stock, Shares Outstanding (in shares)   20,426,158
Entity Shell Company false  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2017 20,426,158      
Balance at Dec. 31, 2017 $ 6,428,997 $ (4,422,957) $ 2,006,040
Stock based compensation - stock options 3,087 3,087
Net loss (202,716) (202,716)
Balance (in shares) at Mar. 31, 2018 20,426,158      
Balance at Mar. 31, 2018 6,432,084 (4,625,673) 1,806,411
Balance (in shares) at Dec. 31, 2017 20,426,158      
Balance at Dec. 31, 2017 6,428,997 (4,422,957) 2,006,040
Net loss       (308,962)
Balance (in shares) at Sep. 30, 2018 20,426,158      
Balance at Sep. 30, 2018 6,439,846 (4,731,919) 1,707,927
Balance (in shares) at Mar. 31, 2018 20,426,158      
Balance at Mar. 31, 2018 6,432,084 (4,625,673) 1,806,411
Stock based compensation - stock options 2,781 2,781
Net loss 147,930 147,930
Balance (in shares) at Jun. 30, 2018 20,426,158      
Balance at Jun. 30, 2018 6,434,865 (4,477,743) 1,957,122
Stock based compensation - stock options 4,981 4,981
Net loss (254,176) (254,176)
Balance (in shares) at Sep. 30, 2018 20,426,158      
Balance at Sep. 30, 2018 6,439,846 (4,731,919) $ 1,707,927
Balance (in shares) at Dec. 31, 2018 20,426,158     20,426,158
Balance at Dec. 31, 2018 6,454,791 (4,834,173) $ 1,620,618
Stock based compensation - stock options 15,558 15,558
Net loss 4,777 4,777
Balance (in shares) at Mar. 31, 2019 20,426,158      
Balance at Mar. 31, 2019 6,470,349 (4,829,396) $ 1,640,953
Balance (in shares) at Dec. 31, 2018 20,426,158     20,426,158
Balance at Dec. 31, 2018 6,454,791 (4,834,173) $ 1,620,618
Net loss       $ (434,492)
Balance (in shares) at Sep. 30, 2019 20,426,158     20,426,158
Balance at Sep. 30, 2019 6,501,982 (5,268,665) $ 1,233,317
Balance (in shares) at Mar. 31, 2019 20,426,158      
Balance at Mar. 31, 2019 6,470,349 (4,829,396) 1,640,953
Stock based compensation - stock options 15,730 15,730
Net loss 85,184 85,184
Balance (in shares) at Jun. 30, 2019 20,426,158      
Balance at Jun. 30, 2019 6,486,079 (4,744,212) 1,741,867
Stock based compensation - stock options 15,903 15,903
Net loss (524,453) $ (524,453)
Balance (in shares) at Sep. 30, 2019 20,426,158     20,426,158
Balance at Sep. 30, 2019 $ 6,501,982 $ (5,268,665) $ 1,233,317
XML 15 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Note 5 - Stock-based Compensation (Details Textual) - USD ($)
9 Months Ended
Aug. 10, 2016
Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum 10.00% 30.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   2,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number   680,000
Share-based Payment Arrangement, Expense   $ 47,191
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount   $ 118,409
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   0
Share-based Payment Arrangement, Option [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition   2 years 47 days
XML 16 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Concentrations 100.00% 100.00%
Largest Client [Member]    
Concentrations 20.00% 41.00%
Second Largest Client [Member]    
Concentrations 20.00% 20.00%
Third Largest Client [member]    
Concentrations 14.00% 16.00%
Next Three Largest Clients [Member]    
Concentrations 26.00% 18.00%
All Other Clients [Member]    
Concentrations 20.00% 5.00%
XML 17 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Note 4 - Capitalized Software Development Costs
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Research, Development, and Computer Software Disclosure [Text Block]
Note
4:
Capitalized Software Development Costs
 
 
Costs incurred to develop Software as a Service (SaaS) technology consist of external direct costs of materials and services and payroll and payroll-related costs for employees who directly devote time to the project. Research and development costs incurred during the preliminary project stage are expensed as incurred. Capitalization begins when technological feasibility is established. Costs incurred during the operating stage of the software application relating to upgrades and enhancements are capitalized to the extent that they result in the extended life of the product. All other costs are expensed as incurred. There were
no
capitalizable costs during the
three
and
nine
months ended
September 30, 2019
and
2018.
 
Amortization of software development costs commenced when the product was available for general release to customers. The capitalized costs are amortized on a straight-line basis over the
three
-year expected useful life of the software. Capitalized software development costs, net of amortization, were
$12,070
and
$108,968
as of
September 30, 2019
and
December 31, 2018,
respectively. Amortization expense incurred during the
three
months ended
September 30, 2019
and
2018
was
$19,753
and
$48,458,
respectively, and during the
nine
months ended
September 30, 2019
and
2018
was
$96,898
and
$145,375,
respectively, and is included in cost of goods sold in the consolidated statements of operations.
XML 18 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Note 8 - Basic and Diluted Net Income (Loss) Per Share
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Earnings Per Share [Text Block]
Note
8:
Basic and Diluted Net Income / (Loss) per Share
 
Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the
three
and
nine
months ended
September 30, 2019
and
2018,
the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net income / (loss) per share basic and diluted are equal in all periods presented. Securities that were
not
included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of
680,000
and
1,350,000
for the
three
and
nine
months ended
September 30, 2019
and
2018,
respectively.
 
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2019
   
2018
   
2019
   
2018
 
Net loss
  $
(524,453
)   $
(254,176
)   $
(434,492
)   $
(308,962
)
Basic and diluted weighted average
                               
common shares outstanding
   
20,426,158
     
20,426,158
     
20,426,158
     
20,426,158
 
                                 
Net loss per share, basic and diluted
  $
(0.03
)   $
(0.01
)   $
(0.02
)   $
(0.02
)
XML 19 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Note 2 - Recent Accounting Pronouncements (Details Textual)
Jan. 01, 2019
USD ($)
Operating Lease, Right-of-Use Asset $ 34,000
Operating Lease, Liability, Total $ 34,000
XML 20 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Note 3 - Revenues 1 (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue, Remaining Performance Obligation, Amount $ 97,187   $ 97,187  
Contract with Customer, Liability, Revenue Recognized $ 0 $ 0 $ 122,238 $ 80,057
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Note 5 - Stock-based Compensation
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
Note
5:
Stock-Based Compensation
 
Our stock-based compensation plan was originally established in
2008.
The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could
not
exceed
30%
of any outstanding issue or
2,500,000
shares, whichever was the lower amount.
 
In
December 2015,
we adopted a revised share option plan in which Plan Shares cannot exceed
10%
of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a
10
-year term. This share option plan was approved by the Company’s shareholders at the annual meeting of shareholders on
August 10, 2016.
 
To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin
No.
110.
The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.
 
 
The following table summarizes our stock option activity for the
nine
months ended
September 30, 2019:
  
   
 
 
 
 
 
 
 
 
Weighted
   
 
 
 
   
 
 
 
 
Weighted
   
Average
   
 
 
 
   
 
 
 
 
Average
   
Remaining
   
Aggregate
 
   
Number of
   
Exercise
   
Contractual
   
Intrinsic
 
   
Shares
   
Price
   
Term (in years)
   
Value
 
Outstanding at December 31, 2018
   
2,040,000
    $
0.47
     
6.63
     
-
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Cancelled
   
(900,000
)    
0.63
     
-
     
-
 
Forfeited or expired
   
-
     
-
     
-
     
-
 
Outstanding at September 30, 2019
   
1,140,000
    $
0.35
     
6.50
     
-
 
                                 
Exercisable at September 30, 2019
   
680,000
    $
0.43
     
4.89
    $
-
 
 
At
September 30, 2019,
680,000
stock options were exercisable and
$47,191
of total compensation cost related to share-based compensation grants had been recognized for the
nine
months ended
September 30, 2019.
Unrecognized compensation expense from stock options was
$118,409
at
September 30, 2019,
which is expected to be recognized over a weighted-average vesting period of
2.13
years beginning
October 1, 2019.
 
There were
no
options granted during the
nine
months ended
September 30, 2019.
 
A summary of the status of the Company’s nonvested options as of
September 30, 2019,
is presented below:
 
Nonvested options
 
 
 
 
   
Number of
 
   
Shares
 
Nonvested options at December 31, 2018
   
690,000
 
Granted
   
-
 
Exercised
   
-
 
Cancelled
   
-
 
Forfeited or expired
   
-
 
Vested
   
(230,000
)
Nonvested options at September 30, 2019
   
460,000
 
XML 22 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Note 5 - Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2019
Notes Tables  
Share-based Payment Arrangement, Activity [Table Text Block]
   
 
 
 
 
 
 
 
 
Weighted
   
 
 
 
   
 
 
 
 
Weighted
   
Average
   
 
 
 
   
 
 
 
 
Average
   
Remaining
   
Aggregate
 
   
Number of
   
Exercise
   
Contractual
   
Intrinsic
 
   
Shares
   
Price
   
Term (in years)
   
Value
 
Outstanding at December 31, 2018
   
2,040,000
    $
0.47
     
6.63
     
-
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Cancelled
   
(900,000
)    
0.63
     
-
     
-
 
Forfeited or expired
   
-
     
-
     
-
     
-
 
Outstanding at September 30, 2019
   
1,140,000
    $
0.35
     
6.50
     
-
 
                                 
Exercisable at September 30, 2019
   
680,000
    $
0.43
     
4.89
    $
-
 
Schedule of Nonvested Share Activity [Table Text Block]
Nonvested options
 
 
 
 
   
Number of
 
   
Shares
 
Nonvested options at December 31, 2018
   
690,000
 
Granted
   
-
 
Exercised
   
-
 
Cancelled
   
-
 
Forfeited or expired
   
-
 
Vested
   
(230,000
)
Nonvested options at September 30, 2019
   
460,000
 
EXCEL 23 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 24 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 25 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue, net        
Revenue, net $ 453,226 $ 933,836 $ 2,640,664 $ 2,952,344
Cost of goods sold        
Cost of goods sold 343,862 622,428 1,170,428 1,660,632
Gross profit 109,364 311,408 1,470,236 1,291,712
Expenses        
Salaries and wages 282,883 251,111 870,813 684,029
Contract services 54,590 47,202 126,928 161,453
Other general and administrative 289,462 262,851 896,032 749,612
Total expenses 626,935 561,164 1,893,773 1,595,094
Net operating loss (517,571) (249,756) (423,537) (303,382)
Interest expense (483) (645) (2,238) (1,048)
Other income (expense), net (6,399) (3,775) (8,717) (4,532)
Net loss $ (524,453) $ (254,176) $ (434,492) $ (308,962)
Net loss per share-basic and diluted (in dollars per share) $ (0.03) $ (0.01) $ (0.02) $ (0.02)
Weighted average common shares outstanding-basic and diluted (in shares) 20,426,158 20,426,158 20,426,158 20,426,158
Service [Member]        
Revenue, net        
Revenue, net $ 401,318 $ 772,081 $ 2,497,083 $ 2,567,153
Product and Service, Other [Member]        
Revenue, net        
Revenue, net 51,908 161,755 143,581 385,191
Cost of goods sold        
Cost of goods sold 39,228 215,007 270,138 540,130
Product [Member]        
Cost of goods sold        
Labor $ 304,634 $ 407,421 $ 900,290 $ 1,120,502
XML 26 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 89 196 1 false 15 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.mcorpcx.com/20190930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.mcorpcx.com/20190930/role/statement-consolidated-balance-sheets-current-period-unaudited Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.mcorpcx.com/20190930/role/statement-consolidated-balance-sheets-current-period-unaudited-parentheticals Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.mcorpcx.com/20190930/role/statement-consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Sheet http://www.mcorpcx.com/20190930/role/statement-consolidated-statements-of-changes-in-shareholders-equity-unaudited Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.mcorpcx.com/20190930/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization and Basis of Presentation Sheet http://www.mcorpcx.com/20190930/role/statement-note-1-organization-and-basis-of-presentation Note 1 - Organization and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Recent Accounting Pronouncements Sheet http://www.mcorpcx.com/20190930/role/statement-note-2-recent-accounting-pronouncements Note 2 - Recent Accounting Pronouncements Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Revenues Sheet http://www.mcorpcx.com/20190930/role/statement-note-3-revenues Note 3 - Revenues Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Capitalized Software Development Costs Sheet http://www.mcorpcx.com/20190930/role/statement-note-4-capitalized-software-development-costs- Note 4 - Capitalized Software Development Costs Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Stock-based Compensation Sheet http://www.mcorpcx.com/20190930/role/statement-note-5-stockbased-compensation Note 5 - Stock-based Compensation Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Concentrations Sheet http://www.mcorpcx.com/20190930/role/statement-note-6-concentrations- Note 6 - Concentrations Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Going Concern Sheet http://www.mcorpcx.com/20190930/role/statement-note-7-going-concern Note 7 - Going Concern Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share Sheet http://www.mcorpcx.com/20190930/role/statement-note-8-basic-and-diluted-net-income-loss-per-share Note 8 - Basic and Diluted Net Income (Loss) Per Share Notes 14 false false R15.htm 014 - Disclosure - Note 5 - Stock-based Compensation (Tables) Sheet http://www.mcorpcx.com/20190930/role/statement-note-5-stockbased-compensation-tables Note 5 - Stock-based Compensation (Tables) Tables http://www.mcorpcx.com/20190930/role/statement-note-5-stockbased-compensation 15 false false R16.htm 015 - Disclosure - Note 6 - Concentrations (Tables) Sheet http://www.mcorpcx.com/20190930/role/statement-note-6-concentrations-tables Note 6 - Concentrations (Tables) Tables http://www.mcorpcx.com/20190930/role/statement-note-6-concentrations- 16 false false R17.htm 016 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share (Tables) Sheet http://www.mcorpcx.com/20190930/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-tables Note 8 - Basic and Diluted Net Income (Loss) Per Share (Tables) Tables http://www.mcorpcx.com/20190930/role/statement-note-8-basic-and-diluted-net-income-loss-per-share 17 false false R18.htm 017 - Disclosure - Note 2 - Recent Accounting Pronouncements (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-2-recent-accounting-pronouncements-details-textual Note 2 - Recent Accounting Pronouncements (Details Textual) Details 18 false false R19.htm 018 - Disclosure - Note 3 - Revenues 1 (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-3-revenues-1-details-textual Note 3 - Revenues 1 (Details Textual) Details http://www.mcorpcx.com/20190930/role/statement-note-3-revenues 19 false false R20.htm 019 - Disclosure - Note 3 - Revenues 2 (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-3-revenues-2-details-textual Note 3 - Revenues 2 (Details Textual) Details http://www.mcorpcx.com/20190930/role/statement-note-3-revenues 20 false false R21.htm 020 - Disclosure - Note 4 - Capitalized Software Development Costs (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-4-capitalized-software-development-costs-details-textual Note 4 - Capitalized Software Development Costs (Details Textual) Details http://www.mcorpcx.com/20190930/role/statement-note-4-capitalized-software-development-costs- 21 false false R22.htm 021 - Disclosure - Note 5 - Stock-based Compensation (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-5-stockbased-compensation-details-textual Note 5 - Stock-based Compensation (Details Textual) Details http://www.mcorpcx.com/20190930/role/statement-note-5-stockbased-compensation-tables 22 false false R23.htm 022 - Disclosure - Note 5 - Stock-based Compensation - Stock Option Activity (Details) Sheet http://www.mcorpcx.com/20190930/role/statement-note-5-stockbased-compensation-stock-option-activity-details Note 5 - Stock-based Compensation - Stock Option Activity (Details) Details 23 false false R24.htm 023 - Disclosure - Note 5 - Stock-based Compensation - Nonvested Options (Details) Sheet http://www.mcorpcx.com/20190930/role/statement-note-5-stockbased-compensation-nonvested-options-details Note 5 - Stock-based Compensation - Nonvested Options (Details) Details 24 false false R25.htm 024 - Disclosure - Note 6 - Concentrations (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-6-concentrations-details-textual Note 6 - Concentrations (Details Textual) Details http://www.mcorpcx.com/20190930/role/statement-note-6-concentrations-tables 25 false false R26.htm 025 - Disclosure - Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) Sheet http://www.mcorpcx.com/20190930/role/statement-note-6-concentrations-percentage-of-sales-and-the-concentrations-details Note 6 - Concentrations - Percentage of Sales and the Concentrations (Details) Details 26 false false R27.htm 026 - Disclosure - Note 7 - Going Concern (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-7-going-concern-details-textual Note 7 - Going Concern (Details Textual) Details http://www.mcorpcx.com/20190930/role/statement-note-7-going-concern 27 false false R28.htm 027 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share (Details Textual) Sheet http://www.mcorpcx.com/20190930/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-details-textual Note 8 - Basic and Diluted Net Income (Loss) Per Share (Details Textual) Details http://www.mcorpcx.com/20190930/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-tables 28 false false R29.htm 028 - Disclosure - Note 8 - Basic and Diluted Net Income (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Sheet http://www.mcorpcx.com/20190930/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-computations-for-basic-and-diluted-net-income-loss-per-share-details Note 8 - Basic and Diluted Net Income (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) Details http://www.mcorpcx.com/20190930/role/statement-note-8-basic-and-diluted-net-income-loss-per-share-tables 29 false false All Reports Book All Reports mccx-20190930.xml mccx-20190930.xsd mccx-20190930_cal.xml mccx-20190930_def.xml mccx-20190930_lab.xml mccx-20190930_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 27 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Note 2 - Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Note
2:
Recent Accounting Pronouncements
 
In
February 2016,
the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”)
No.
2016
-
02,
“Leases (Topic
842
)” (“ASU
2016
-
02”
) to increase the transparency and comparability about leases among entities. Additional ASUs have been issued subsequent to ASU
2016
-
02
to provide supplementary clarification and implementation guidance for leases related to, among other things, the application of certain practical expedients, the rate implicit in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. ASU
2016
-
02
and these additional ASUs are now codified as Accounting Standards Codification Standard
842
- “Leases” (“ASC
842”
). ASC
842
supersedes the lease accounting guidance in Accounting Standards Codification
840
“Leases” (“ASC
840”
) and requires lessees to recognize a lease liability and a corresponding lease asset for virtually all lease contracts. It also requires additional disclosures about leasing arrangements. The Company’s consolidated financial statements for the periods prior to the adoption of ASC
842
are
not
adjusted and are reported in accordance with the Company’s historical accounting policy. As of the date of implementation on
January 1, 2019,
the impact of the adoption of ASC
842
resulted in the recognition of a right of use asset, included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of approximately
$34,000
.
We elected the package of practical expedients permitted under the transition guidance.
 
As the right of use asset and the lease payable obligation were the same upon adoption of ASC
842,
there was
no
cumulative effect impact on the Company’s retained earnings.
 
In
February 2018,
the FASB issued ASU
2018
-
02,
Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income. The ASU amends ASC
220,
Income Statement — Reporting Comprehensive Income, to “allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act.” In addition, under the ASU, an entity will be required to provide certain disclosures regarding standard tax effects. The ASU is effective for all entities for fiscal years beginning after
December 15, 2018,
and interim periods within those fiscal years. The Company adopted ASU
2018
-
02
effective
January 1, 2019.
The adoption of this standard did
not
have a material impact on the consolidated financial statements.
 
XML 28 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Note 5 - Stock-based Compensation - Stock Option Activity (Details) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Options outstanding, balance (in shares) 2,040,000  
Weighted average exercise price, outstanding balance (in dollars per share) $ 0.47  
Weighted average remaining contractual term, outstanding balance (Year) 6 years 182 days 6 years 229 days
Options granted (in shares) 0  
Weighted average exercise price, options granted (in dollars per share)  
Options exercised (in shares)  
Weighted average exercise price, options exercised (in dollars per share)  
Options cancelled (in shares) (900,000)  
Weighted average exercise price, options cancelled (in dollars per share) $ 0.63  
Options outstanding, balance (in shares) 1,140,000 2,040,000
Weighted average exercise price, outstanding balance (in dollars per share) $ 0.35 $ 0.47
Options exercisable (in shares) 680,000  
Weighted average exercise price, options exercisable (in dollars per share) $ 0.43  
Weighted average remaining contractual term, options exercisable (Year) 4 years 324 days  
XML 29 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Note 7 - Going Concern (Details Textual)
Sep. 30, 2019
USD ($)
Working Capital $ 1,063,401
XML 30 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Note 7 - Going Concern
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
Note
7:
Going Concern
 
The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.
 
We have had material operating losses and have
not
yet created positive cash flows for a full year. These factors raise substantial doubt as to our ability to continue as a going concern. However, we continue to improve our core consulting services revenue and are seeking ways and have implemented plans to reduce operating cost in order to increase our net operating income. In an effort to reduce operating losses and generate positive cash flow, we have initiated cost containment plans that include but are
not
limited to an agreement with the Interim Chief Executive Officer that he will
not
take any cash compensation from the Company until such time that he and the Board mutually determine.  We continue to focus on our sales pipeline of new business and our cost reduction plans to improve upon our positive working capital of
$1,063,401
at
September 30, 2019. 
These measures combined with our positive working capital position should enable us to meet our liquidity needs over the next
12
months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do
not
include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Note 8 - Basic and Diluted Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2019
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2019
   
2018
   
2019
   
2018
 
Net loss
  $
(524,453
)   $
(254,176
)   $
(434,492
)   $
(308,962
)
Basic and diluted weighted average
                               
common shares outstanding
   
20,426,158
     
20,426,158
     
20,426,158
     
20,426,158
 
                                 
Net loss per share, basic and diluted
  $
(0.03
)   $
(0.01
)   $
(0.02
)   $
(0.02
)
ZIP 32 0001437749-19-022908-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-19-022908-xbrl.zip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�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htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 769,145 $ 1,350,014
Accounts receivable 565,470 343,036
Total current assets 1,334,615 1,693,050
Long term assets:    
Property and equipment, net 88,182 90,074
Capitalized software development costs, net 12,070 108,968
Other assets 69,664 72,876
Total assets 1,504,531 1,964,968
Liabilities:    
Accounts payable and accrued liabilities 157,596 220,576
Deferred revenue 97,187 122,238
Lease payable 14,749
Other current liabilities 1,682 1,536
Total current liabilities 271,214 344,350
Total liabilities 271,214 344,350
Shareholders' equity:    
Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at September 30, 2019 and December 31, 2018
Additional paid-in capital 6,501,982 6,454,791
Accumulated deficit (5,268,665) (4,834,173)
Total shareholders' equity 1,233,317 1,620,618
Total liabilities and shareholders' equity $ 1,504,531 $ 1,964,968
XML 34 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (434,492) $ (308,962)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation, and amortization 98,790 153,074
Operating lease ROU asset amortization 20,498
Stock compensation expense 47,191 10,849
Changes in operating assets and liabilities:    
Accounts receivable (222,434) (207,134)
Other assets 18,546 (35,359)
Accounts payable and accrued liabilities (62,980) 263,584
Lease liability (21,083)
Other current liabilities 146 2,150
Deferred revenue (25,051) (11,714)
Net cash used in operating activities (580,869) (133,512)
INVESTING ACTIVITIES    
Equipment purchases (4,474)
Net cash used in investing activities (4,474)
FINANCING ACTIVITIES    
Repayment of notes payable (8,169)
Net cash used in financing activities (8,169)
Decrease in cash and cash equivalents (580,869) (146,155)
Cash and cash equivalents, beginning of period 1,350,014 1,616,076
Cash and cash equivalents, end of period 769,145 1,469,921
Supplemental disclosure of cash flow information:    
Interest paid 2,238 1,048
Non-cash transactions:    
ROU asset and operating lease obligation recognized upon adoption of ASU 2016-02 $ 34,164
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Note 4 - Capitalized Software Development Costs (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Capitalized Computer Software, Additions $ 0 $ 0 $ 0 $ 0  
Capitalized Computer Software, Useful Life     3 years    
Capitalized Computer Software, Net, Ending Balance 12,070   $ 12,070   $ 108,968
Capitalized Computer Software, Amortization $ 19,753 $ 48,458 $ 96,898 $ 145,375  
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Note 6 - Concentrations (Details Textual)
$ in Thousands
Sep. 30, 2019
USD ($)
Accounts Receivable, Allowance for Credit Loss, Ending Balance $ 0
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Note 8 - Basic and Diluted Net Income (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Net loss $ (524,453) $ 85,184 $ 4,777 $ (254,176) $ 147,930 $ (202,716) $ (434,492) $ (308,962)
Basic and diluted weighted average common shares outstanding (in shares) 20,426,158     20,426,158     20,426,158 20,426,158
Net loss per share, basic and diluted (in dollars per share) $ (0.03)     $ (0.01)     $ (0.02) $ (0.02)
XML 39 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
$ / shares in Thousands
Sep. 30, 2019
Dec. 31, 2018
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 20,426,158 20,426,158
Common stock, shares outstanding (in shares) 20,426,158 20,426,158
XML 40 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Note 1 - Organization and Basis of Presentation
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note
1:
Organization and Basis of Presentation
 
McorpCX, Inc. (“we,” “us,” “our,” or the “Company””) was incorporated in the State of California on
December 14, 2001.
We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective
October 18, 2011.
During
Q1
2015,
the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On
June 11, 2015,
at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc.
 
The Company formed a wholly owned subsidiary, McorpCX, LLC (“McorpCX LLC”) as a limited liability company in the state of Delaware on
December 14, 2017.
On
August 16, 2018,
the Company entered into a contribution agreement with its wholly owned subsidiary McorpCX LLC, pursuant to which the Company transferred to McorpCX LLC all of the Company’s assets and liabilities related to the Company’s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company.
 
We are a customer experience services company, delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization. 
 
The consolidated financial statements and related disclosures as of and for the
three
and
nine
months ended
September 30, 2019
and
2018,
are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of
December 31, 2018
was derived from the audited consolidated financial statements included in our Annual Report on Form
10
-K for the year ended
December 31, 2018.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended
December 31, 2018,
filed on Form
10
-K with the SEC on
April 1, 2019. 
The results of operations for the
three
and
nine
months ended
September 30, 2019,
are
not
necessarily indicative of the results to be expected for the full year.
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Note 8 - Basic and Diluted Net Income (Loss) Per Share (Details Textual) - shares
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 680,000 1,350,000
XML 42 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Note 3 - Revenues 2 (Details Textual)
Sep. 30, 2019
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 1 year
XML 43 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Note 5 - Stock-based Compensation - Nonvested Options (Details)
9 Months Ended
Sep. 30, 2019
shares
Nonvested options at December 31, 2018 (in shares) 690,000
Vested (in shares) (230,000)
Nonvested options at September 30, 2019 (in shares) 460,000
XML 44 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Note 6 - Concentrations
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]
Note
6:
Concentrations
 
 
We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune
500
companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the
nine
months ended
September 30, 2019
and
2018,
the percentage of sales and the concentrations are:
 
   
2019
   
2018
 
Largest client
   
20
%    
41
%
Second largest client
   
20
%    
20
%
Third largest client
   
14
%    
16
%
Next three largest clients
   
26
%    
18
%
All other clients
   
20
%    
5
%
     
100
%    
100
%
 
Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is
no
provision made to include an allowance for doubtful accounts.
XML 45 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Note 6 - Concentrations (Tables)
9 Months Ended
Sep. 30, 2019
Notes Tables  
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
   
2019
   
2018
 
Largest client
   
20
%    
41
%
Second largest client
   
20
%    
20
%
Third largest client
   
14
%    
16
%
Next three largest clients
   
26
%    
18
%
All other clients
   
20
%    
5
%
     
100
%    
100
%
XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }